Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Ukurasa 1 kutoka 163 matokeo
Method for identifying suppressor mutations for common p53 cancer mutations
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION
More than half of all human cancers are associated with one or more alterations in the tumor suppressor gene TP53 (1-4). Many premalignant lesions, a subset of malignant clones, and germlines of families prone to cancer are characterized by the presence of one wild-type
Method of treating cancer using IL2R beta/common gamma chain antibodies
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
CROSS RELATED APPLICATIONS
This application claims the benefit of Singapore Serial No. 10201506227V, filed Aug. 6, 2015, the contents of which are incorporated herein by reference.
FIELD OF THE INVENTION
The present invention relates to antibodies that bind to interleukin 2 receptor .beta.
Common antigen for colorectal and mucinous ovarian tumors and process for isolating the same
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION
This invention relates to identification of a new common antigen of colorectal and mucinous ovarian tumors (COTA) and to a process for isolating the same. This invention also relates to clinical application of COTA and anti-COTA antibodies in detection and diagnosis of
Peptide epitopes common to antigens of the same multigene family
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
CROSS-REFERENCE TO RELATED APPLICATION
This application is a national stage of the international application PCT/FR03/00970, filed March 27, 2003, which claims benefit of the application FR 02/03888, filed Mar. 28, 2002.
The present invention relates to peptides representing shared epitopes of tumor
Identification of a gene causing the most common form of bardet-biedl syndrome and uses thereof
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the fields of genetics and molecular biology. More particular the invention relates to the identification of a gene that is involved in Bardet-Biedl Syndrome (BBS), designated here as BBS1. Defects in this gene
Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD AND BACKGROUND OF THE INVENTION
The present invention relates to methods of treating cancer using antibodies directed against p53 mutant proteins.
The tumor suppressor gene p53 inhibits tumor growth primarily via induction of apoptosis. Mutations in the p53 tumor suppressor gene are the most
Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD AND BACKGROUND OF THE INVENTION
The present invention relates to methods of treating cancer using antibodies directed against p53 mutant proteins.
The tumor suppressor gene p53 inhibits tumor growth primarily via induction of apoptosis. Mutations in the p53 tumor suppressor gene are the most
Anti-cervical cancer compound and method of use thereof
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF INVENTION
The present invention relates to a method for treating cancer using an anti-cancer compound. More particularly, said anti-cancer compound is an anti-cervical-cancer compound. The present invention has a specific application in treating human cervical cancer.
BACKGROUND OF
Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION
(a) Field of the Invention
The invention relates to the use of antisense oligonucleotides directed against specific cellular receptors, alone or in combination, in order to inhibit the inflammatory reaction that is present in asthma, hypereosinophilia or atopic diseases
Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION
(a) Field of the Invention
The invention relates to the use of antisense oligonucleotides directed against specific cellular receptors, alone or in combination, in order to inhibit the inflammatory reaction that is present in asthma, hypereosinophilia or atopic diseases
Oligonucleotides for treating inflammation and neoplastic cell proliferation
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION
The invention relates to the use of antisense oligonucleotides directed against specific cellular receptors, alone or in combination, in order to inhibit general inflammation, including inflammation associated with asthma, COPD, allergy, Cystic fibrosis (CF), and
In situ tumor temperature profile measuring probe and method
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION
The present invention generally relates to breast tumor screening devices and methods and, more particularly, is concerned with an in situ tumor temperature profile measuring probe and a method of using the probe.
The early detection of tumors, which is the principal
In situ tumor temperature profile measuring probe and method
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION
The present invention generally relates to breast tumor screening devices and methods and, more particularly, is concerned with an in situ tumor temperature profile measuring probe and a method of using the probe.
The early detection of tumors, which is the principal
Use of EGFR biomarkers for the treatment of gastric cancer with anti-EGFR agents
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the national stage of International Patent Application No. PCT/US2014/20714, filed Mar. 14, 2014, which claims priority to, and the benefit of International Patent Application No. PCT/CN2013/072638, filed on Mar. 14, 2013, each of which is
Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the provision of novel means for the diagnosis and therapy of cancers characterized by overexpression of gene products from the myc family. These means essentially include the use of monoclonal antibodies
Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi
- Inafanya kazi katika lugha 55
- Uponyaji wa mitishamba unaungwa mkono na sayansi
- Kutambua mimea kwa picha
- Ramani ya GPS inayoshirikiana
- Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
- Tafuta mimea ya dawa na athari zao
- Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu
Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa
